Peter J. Courossi
Directeur/Membre du Conseil chez TRACT Therapeutics, Inc.
Profil
Peter J.
Courossi is currently the Chief Business Officer & Director at TRACT Therapeutics, Inc. He previously held positions as Director at KeraCure, Inc., Principal at Millennium Pharmaceuticals, Inc. and TransForm Pharmaceuticals, Inc., Chief Financial Officer at Sention, Inc., Acceleron Pharma, Inc., Alinea Pharmaceuticals, Inc., Visterra, Inc., AVEO Pharmaceuticals, Inc., Genzyme Tissue Repair, and Civitas Therapeutics, Inc. Courossi earned an MBA from Babson College.
Postes actifs de Peter J. Courossi
Sociétés | Poste | Début |
---|---|---|
TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services TRACT Therapeutics, Inc. develops revolutionary therapeutic cells. The company was founded by Gretchen S. Johnson and Joseph R. Leventhal and is headquartered in Chicago, IL. | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter J. Courossi
Sociétés | Poste | Fin |
---|---|---|
VISTERRA INC | Directeur Financier/CFO | 02/12/2013 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Directeur Financier/CFO | - |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Genzyme Tissue Repair
Genzyme Tissue Repair BiotechnologyHealth Technology Genzyme Tissue Repair develops biological products and devices for orthopedic injuries such as cartilage damage and severe burns. The company is headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Formation de Peter J. Courossi
Babson College | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 11 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
KeraCure, Inc.
KeraCure, Inc. Medical DistributorsDistribution Services KeraCure, Inc. develops and manufactures health care products. It improves natural regenerative process of the human body. The firm's products include the KeraPac a living tissue that stimulates the body’s own natural healing process by activating ability to repair and regenerate tissue The company was founded in 1999 by Riley S. Rees and is headquartered in Chicago, IL. | Distribution Services |
Sention, Inc.
Sention, Inc. Pharmaceuticals: MajorHealth Technology Sention, Inc. manufactures pharmaceutical products. The company focuses on the discovery and development of drugs to treat memory impairment and other central nervous disorders. The company was founded in 1999 and is headquartered in Providence, RI | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Alinea Pharmaceuticals, Inc.
Alinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alinea Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing new therapeutics for the treatment of diabetes and metabolic disorders. The company was founded in August 2005 and is headquartered in Cambridge, MA. | Health Technology |
Visterra, Inc.
Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA. | Health Technology |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Tissue Repair
Genzyme Tissue Repair BiotechnologyHealth Technology Genzyme Tissue Repair develops biological products and devices for orthopedic injuries such as cartilage damage and severe burns. The company is headquartered in Cambridge, MA | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services TRACT Therapeutics, Inc. develops revolutionary therapeutic cells. The company was founded by Gretchen S. Johnson and Joseph R. Leventhal and is headquartered in Chicago, IL. | Commercial Services |